|
PPM1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.40260003611559E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.42780000045306E-08 |
| Normal-vs-Stage2 |
1.039780E-03 |
| Normal-vs-Stage3 |
2.83229999453738E-08 |
| Normal-vs-Stage4 |
4.19650000305083E-08 |
| Stage1-vs-Stage2 |
3.819000E-01 |
| Stage1-vs-Stage3 |
2.659400E-01 |
| Stage1-vs-Stage4 |
1.573570E-01 |
| Stage2-vs-Stage3 |
1.423820E-01 |
| Stage2-vs-Stage4 |
7.762400E-02 |
| Stage3-vs-Stage4 |
6.225600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74930000987439E-09 |
| Normal-vs-AfricanAmerican |
1.574090E-02 |
| Normal-vs-Asian |
2.7707000005428E-07 |
| Caucasian-vs-AfricanAmerican |
2.024000E-01 |
| Caucasian-vs-Asian |
4.808400E-01 |
| AfricanAmerican-vs-Asian |
9.462500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.52169998613294E-09 |
| Normal-vs-Female |
1.5669999964274E-08 |
| Male-vs-Female |
4.676600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.99110000043135E-07 |
| Normal-vs-Age(41-60Yrs) |
2.28409999802892E-08 |
| Normal-vs-Age(61-80Yrs) |
2.00050000009888E-07 |
| Normal-vs-Age(81-100Yrs) |
1.279550E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.161200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.440000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.397400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.062000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.507400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.704400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.179030E-01 |
| Classical-VS-Follicular |
4.478400E-01 |
| Classical-VS-Other |
3.463800E-01 |
| Classical-VS-Normal |
7.00950000265266E-08 |
| Tall-VS-Follicular |
3.072200E-01 |
| Tall-VS-Other |
8.762600E-01 |
| Tall-VS-Normal |
5.49519999948345E-07 |
| Follicular-VS-Other |
5.639200E-01 |
| Follicular-VS-Normal |
4.86099999996714E-06 |
| Other-VS-Normal |
7.102400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.55889999692494E-08 |
| Normal-vs-N1 |
6.00239999926089E-08 |
| N0-vs-N1 |
2.737600E-01 |
|
|
